Profhilo is an injectable skin treatment made from highly purified hyaluronic acid (HA). Its not a traditional filler that adds volume. Instead its designed to hydrate, stimulate collagen and elastin production, and remodel skin quality from within. HA attracts and holds water which plumps and hydrates tissue while triggering fibroblasts to make new collagen and elastin. This gives a gradual improvement in skin firmness, elasticity, and texture.
Our dataset currently has 9 clinic(s), with approximately 278 reviews and an average rating of 4.9.
Medical Infrastructure:
- Tunbridge Wells Hospital (Maidstone and Tunbridge Wells NHS Trust)
- Multiple CQC-registered independent hospitals and specialist dermatology/plastic surgery clinics
- Strong private insurer integration
Local Aethetics Market:
Highly mature, consultant-led aesthetic and surgical ecosystem
Profhilo itself has regulatory approvals (MHRA and FDA reported in some sources) confirming it's safety profile as an injectable HA treatment. However specific NICE procedural guidance may be limited, and UK practice of cosmetic injectables lacks strict regulation on who can provide treatments, so clinician judgement and adherence to best practices matter.
Local regulatory authority:
- Care Quality Commission (CQC)
- General Medical Council (GMC)
- Royal College of Surgeons (RCS)
Private insurance usage locally:
- High relative to UK average
- Dermatology and medically indicated procedures frequently insurer-funded (Bupa, AXA, Aviva)
- Cosmetic surgery self-funded or finance-supported
Cosmetic finance availability:
- Common for plastic surgery procedures (breast augmentation, liposuction)
- Staged payment plans typical in private hospital sector
Current average rating citywide: 4.9